July 19, 2019
Repurposing

Old wine in a new bottle? Introduction to Drug Repurposing

Translating a discovery in biology to a marketable medical breakthrough is a long drawn, tedious, high-investment, and high-risk process. Drug repurposing / repositioning has turned into a popular strategy of late. Not quite the same as traditional drug development techniques, the strategy is productive, affordable and is associated with reduced […]
September 11, 2017
Targetted therapy

Anti-PD1 and PD-L1 Agents in Development

Distribution of Anti Pd-1 / Anti PD-L1 by Phase
May 31, 2017

Digital Health Abstracts @ ASCO 2017

The remote patient management or tele-healthcare as a concept is only starting to take off in Oncology. The readouts, though limited by their small sample size, have shown positive impact of technology on care providers, patient outcomes and the overall cost burden. Normally, larger studies would be needed to validate […]
May 26, 2017

Prostate Cancer Abstracts – RAS Viewpoint

ASCO 2017 is primarily setting the stage for future as it relates to Prostate Cancer – a large number of presentations are focused on early stage data from new compounds and/or combinations of existing. The truly practice impacting trials such as IMbassador250, ARASENS, PROfound and TRITON3 will be touched upon […]